Discover 1,803 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,803
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
for
Tobacco, Tobacco Abstinence, Smoking Cessation,
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT06883097
Recruiting
FiberLocker® System Augmentation of Rotator Cuff Repairs
for
Rotator Cuff Tear, Rotator Cuff Tears,
Location: Winston-Salem NC, Columbia MD, Chicago IL, Medford OR
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
for
Type 2 Diabetes, Cardiovascular Risk
Location: Winston-Salem NC, Statesville NC, Fort Mill SC,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 45+
Code: NCT07797335
Phase3, Recruiting
Clinical Validation of Omron WheezeScan
for
Asthma in Children, Bronchitis, Bronchiolitis
Location: Winston-Salem NC, Cincinnati OH, New York NY,
Sponsor: Omron Healthcare Co., Ltd.
Sex: All
Age: 0 - 8
Code: NCT04144699
Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Lisle IL, Chapel Hill NC, Raleigh NC, Charlotte NC,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase2, Recruiting
Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal Odor Not Caused by BV or Vaginitis
for
Vaginal Odor
Location: Winston Salem NC, Philadelphia PA, Detroit MI
Sponsor: Abbott Research Group
Sex: Female
Age: 18+
Code: NCT00417365
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age